Ropharma announced non-consolidated earnings results for the year 2014. For the year, the company reported that its net profit grew to RON 8.196 million from RON 7.203 million a year earlier. Operating profit edged down to RON 10.215 million from RON 10.517 million in 2013.

Pre-tax profit stood at RON 10.176 million in 2014, as compared to RON 8.891 million a year earlier. The company's total revenue rose to RON 422.790 million in 2014 from RON 418.413 million in 2013.